Focus: Real Time Genomics is a New Zealand-based biotechnology company specializing in genomic data analysis with a focus on rare and complex disease applications. The company operates as a private entity with a lean, specialized workforce.
Profile data last refreshed 8h ago · AI intelligence enriched 1w ago
Stable — net +3 jobs in 30d
9 added, 6 removed. Backfill posture.
Real Time Genomics represents a high-risk, high-learning-potential opportunity for scientists seeking early-stage biotech immersion; career value hinges on undisclosed funding runway and unannounced clinical progress.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Real Time Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Real Time Genomics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub